Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,266 | N/A | 36,980 | N/A | 2,051 |
| Depreciation Amortization | 21,409 | N/A | 5,289 | N/A | 4,480 |
| Other Working Capital | -45,216 | N/A | -42,400 | N/A | -22,261 |
| Other Operating Activity | 11,780 | 17,749 | 28,517 | 25,778 | 31,599 |
| Operating Cash Flow | $-17,293 | $17,749 | $28,386 | $25,778 | $15,869 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -826 | N/A | N/A | N/A |
| PPE Investments | -25,692 | -6,668 | -9,448 | -3,093 | -6,431 |
| Net Acquisitions | -220,662 | -224,659 | -20,378 | -15,295 | 0 |
| Purchase Sale Intangibles | N/A | -17,109 | N/A | N/A | N/A |
| Other Investing Activity | -39,567 | -26,701 | -59,348 | -11,849 | -10,504 |
| Investing Cash Flow | $-285,921 | $-258,854 | $-89,174 | $-30,237 | $-16,935 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -451 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 676 | N/A | N/A | N/A |
| Other Financing Activity | -3,719 | -3,148 | 421,498 | 1,420 | 6,768 |
| Financing Cash Flow | $-3,719 | $-2,923 | $421,498 | $1,420 | $6,768 |
| Exchange Rate Effect | 8,800 | 11,185 | 26,606 | 137 | -1,112 |
| Beginning Cash Position | 439,999 | 439,999 | 81,299 | 81,287 | 77,289 |
| End Cash Position | 141,866 | 207,156 | 468,615 | 78,385 | 81,879 |
| Net Cash Flow | $-298,133 | $-232,843 | $387,316 | $-2,902 | $4,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,293 | 17,749 | 28,386 | 25,778 | 15,869 |
| Capital Expenditure | N/A | -6,668 | N/A | N/A | N/A |
| Free Cash Flow | -17,293 | 11,081 | 28,386 | 25,778 | 15,869 |